-+ 0.00%
-+ 0.00%
-+ 0.00%

Gain Therapeutics Q2 EPS $(0.11) Beats $(0.14) Estimate

Benzinga·08/11/2026 11:30:00
Listen to the news
Gain Therapeutics (NASDAQ:GANX) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 42.11 percent increase over losses of $(0.19) per share from the same period last year.